Real-world evidence from FLEX: Utility of MammaPrint in guiding treatment planning for patients aged 70 and older with early-stage breast cancer. Performance metrics of LLM-based extraction pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback